Consumer Packaged Goods, Food & Household Brands · Advertiser / Brand
Kimberly-Clark
Consumer goods manufacturer focused on tissue, hygiene and personal care.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Kimberly-Clark Corporation
- Entity type
- COMPANY
- Founded
- 1872
- Company size
- >5,000
- Market cluster / sector
- Consumer Packaged Goods, Food & Household Brands
- Market role
- Advertiser / Brand
- Ticker
- KMB
- Official website
- kimberly-clark.com
What Kimberly-Clark does
Kimberly-Clark creates value by developing, manufacturing, branding and distributing recurring-use consumer staples. Revenue is generated from product sales across established categories such as tissue, personal care and hygiene, with scale manufacturing, procurement, brand equity and shelf distribution forming the core economics of the business.
Category differentiation
Kimberly-Clark is a consumer packaged goods manufacturer and brand owner, not an adtech, martech or enterprise software vendor. It should not be confused with a healthcare provider or medical device company.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Kimberly-Clark is a long-established consumer goods company that manufactures and sells personal care, tissue and hygiene products through retail, wholesale and commercial distribution channels. It operates as a brand owner and packaged goods manufacturer rather than a software or media platform. The company makes money by selling everyday household and personal care products at scale, primarily through large retail networks and other distribution partners, with end demand coming from consumers and institutions. Its customers therefore include retailers, distributors and commercial buyers, while its products are ultimately used by households and professional settings.
Company news briefing
Briefing updated:
Kimberly-Clark is advancing its pending acquisition of Kenvue Inc. with a $7.0 billion note exchange offer, ahead of its expected fourth-quarter closing. Financially, the company reported Q2 2026 net sales of $4.19 billion and completed the divestiture of a 51% stake in its International Family Care and Professional business to Suzano. Operationally, Russell Torres, President and Chief Operating Officer, announced his departure effective November 2026, while the brand continues its community engagement through Huggies initiatives and maintains its standing as a defensive asset for investors.
Business model & monetisation
The company primarily monetises through wholesale and retail product sales, earning gross margin on manufactured branded goods distributed through stores and commercial channels. Its commercial model is product-based rather than subscription-led, with revenue tied to unit sales, pricing, distribution reach and category mix.
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Kimberly-Clark
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Kimberly-Clark's competitive landscape.
Global consumer goods company selling household and personal care brands.
Consumer goods company selling household and personal care brands.
Consumer goods group selling health, hygiene and nutrition brands.
Consumer goods company selling branded household and personal care products.
Hygiene and health products manufacturer for consumers and institutions.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
8-K Financial Filing Analysis for Kimberly-Clark (2026-11-05)
financials · Recorded impact score: 3.5/5
On November 5, 2026, Kimberly-Clark Corporation filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing its financial results for the third quarter ended September 30, 2026. The detailed financial press release was furnished as Exhibit 99.1. In accordance with standard SEC furnishing rules, the information and accompanying exhibit are not deemed 'filed' for liability purposes under Section 18 of the Exchange Act, nor are they incorporated by reference into registration statements under the Securities Act of 1933.
- Kimberly-Clark Corporation furnished its quarterly earnings release for the period ended September 30, 2026, via Exhibit 99.1 on November 5, 2026.
- The filing was executed under Item 2.02 by Senior Vice President and Chief Financial Officer Nelson Urdaneta.
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-20)
financials · Recorded impact score: 4.5/5
On October 19, 2026, Kimberly-Clark Corporation priced a private offering under Rule 144A and Regulation S of senior unsecured notes across five tranches totaling $4.9 billion in aggregate principal amount. The tranches mature between 2028 and 2036, carrying fixed interest coupons ranging from 5.100% to 5.800%. The offering is scheduled to close on or about October 29, 2026, subject to customary closing conditions. The capital raise directly funds the cash consideration, fees, and expenses for Kimberly-Clark's pending acquisition of Kenvue Inc., slated for completion in Q4 2026. The notes feature a special mandatory redemption clause requiring redemption at 101% of principal plus accrued interest if the acquisition does not close by May 31, 2027 (or an agreed outside date) or is abandoned. This transaction solidifies the debt financing structure essential for closing the mega-cap consumer health transaction.
- Kimberly-Clark priced $4.9 billion in senior unsecured notes across five tranches: $750M at 5.100% due 2028, $1.0B at 5.300% due 2029, $1.25B at 5.450% due 2031, $750M at 5.650% due 2034, and $1.15B at 5.800% due 2036.
- Proceeds will finance the cash consideration and expenses for the pending acquisition of Kenvue Inc., expected to close in Q4 2026.
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-15)
financials · Recorded impact score: 4.1/5
Kimberly-Clark Corporation issued a Current Report on Form 8-K to furnish preliminary estimated financial results for the third quarter ended September 30, 2026, while reaffirming its full-year 2026 outlook. The company reported estimated net sales of $4,134 million, reflecting a 0.4% reported net sales decline and a 1.3% contraction in organic sales growth. Operating profit is estimated at $516 million compared to $621 million in Q3 2025, while adjusted operating profit stood relatively stable at $677 million versus $683 million in the prior year. Diluted earnings per share attributable to Kimberly-Clark jumped to $5.37, driven primarily by a $4.33 per share transaction gain on the International Family Care and Professional (IFP) transaction with Suzano S.A., though adjusted EPS attributable to Kimberly-Clark decreased to $1.70 from $1.82. The company incurred $106 million ($0.27 per share) in transaction and advisory costs related to its pending acquisition of Kenvue Inc., along with $55 million in charges under its 2024 Transformation Initiative. Cash and cash equivalents surged to $1,874 million as of September 30, 2026.
- Q3 2026 estimated net sales reached $4,134 million, down 0.4% year-over-year, with organic sales contracting by 1.3%.
- Diluted EPS attributable to Kimberly-Clark rose to $5.37, substantially boosted by an IFP transaction gain of $4.33 per share, while adjusted EPS attributable to the company declined from $1.82 to $1.70.
EU Clears Kenvue Deal; Kimberly-Clark to Divest Tampon Brands
M&A · Recorded impact score: 2/5
The European Commission has conditionally approved Kimberly-Clark's $48.8 billion acquisition of Kenvue, a US consumer goods company, on October 14, 2026. To address antitrust concerns, Kimberly-Clark must divest its feminine care brands—Kotex, Lidie, Camelia, and Record—in the European Economic Area (EEA), including trademarks, intellectual property, technical know-how, key employees, and business relationships. Turkish company Dilek (or Dilek Gıda) has been approved as the buyer. The Commission's investigation focused on tampon markets in Czechia, Estonia, and Slovakia, where the merger would have reduced competition. The merger, notified to the EU on August 25, 2026, combines Kimberly-Clark's hygiene products with Kenvue's health and personal care brands such as Neutrogena and Listerine. Kenvue was spun off from Johnson & Johnson in 2023.
- Kimberly-Clark acquires Kenvue for $48.8 billion, with EU approval granted on October 14, 2026, subject to conditions.
- Kimberly-Clark must divest feminine care brands Kotex, Lidie, Camelia, and Record in the EEA.
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-01)
financials · Recorded impact score: 3.7/5
On September 29, 2026, Kimberly-Clark Corporation was notified by Russell Torres, President and Chief Operating Officer, of his decision to step down from his role effective November 2, 2026, in order to pursue other opportunities. The filing does not immediately name an interim or permanent successor for the COO role. This executive departure marks a significant leadership transition for the consumer goods giant as it manages global operational execution.
- Russell Torres notified Kimberly-Clark on September 29, 2026, of his departure from the roles of President and Chief Operating Officer.
- The effective date of Torres's resignation is November 2, 2026.
Explore company relationships
Questions about Kimberly-Clark
What is Kimberly-Clark?
Kimberly-Clark is a public consumer goods company that manufactures and sells tissue, hygiene and personal care products.
Who uses Kimberly-Clark?
Its products are used by consumers, households and institutional buyers, while retailers and distributors are key direct commercial customers.
How does Kimberly-Clark make money?
It makes money by manufacturing and selling branded consumer staples through retail, wholesale and commercial distribution channels.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
9 publicly documented primary sources and citations linked across the market graph.
Continue your research on Kimberly-Clark
Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Daily intelligent monitoring · Verified primary sources.
Unlock full intelligence profile, ownership & live market signals